| Filed On | Filing |
|---|---|
| 20 Oct 2026 |
Form 4: Bono Raquel C., Director
Received 78,800 shares as a grant or award · Granted 157,400 Stock Option (right to buy) |
| 20 Jul 2026 |
Form 4: Finney Kevin, Director
Received 39,400 shares as a grant or award · Granted 78,700 Stock Options (right to buy) |
| 17 Jul 2026 |
Form 4: Breitmeyer James B, Director
Received 8,315 shares as a grant or award · Granted 16,610 Stock Options (right to buy) |
| 17 Jul 2026 |
Form 4: Heron Elaine J, Director
Received 39,400 shares as a grant or award · Granted 78,700 Stock Options (right to buy) |
| 17 Jul 2026 |
Form 4: Watson W. Mark, Director
Received 39,400 shares as a grant or award · Granted 78,700 Stock Options (right to buy) |
| 17 Jul 2026 |
Form 4: Wheadon David E., Director
Received 39,400 shares as a grant or award · Granted 78,700 Stock Options (right to buy) |
| 26 May 2026 |
Form 4: Watson W. Mark, Director
Bought 10,000 shares ($6.53K) |
| 21 May 2026 |
Form 4: Grasman Jeroen Nicolaas, Chief Financial Officer
Gave up 31,395 shares to cover exercise price or tax ($19.2K) |
| 01 May 2026 |
Form 4: Breitmeyer James B, Director
Received 78,800 shares as a grant or award · Granted 157,400 Stock Option (right to buy) |
| 31 Mar 2026 |
Form 4: Tucker Sean, SVP, Chief Scientific Officer
Gave up 3,924 shares to cover exercise price or tax ($2.55K) |
| 31 Mar 2026 |
Form 4: Cummings James F., Chief Medical Officer
Gave up 3,292 shares to cover exercise price or tax ($2.14K) |
| 26 Mar 2026 |
Form 4: Berg Edward B, SVP, General Counsel
Gave up 36,418 shares to cover exercise price or tax ($25.3K) |
| 26 Mar 2026 |
Form 4: Cummings James F., Chief Medical Officer
Gave up 30,551 shares to cover exercise price or tax ($21.2K) |
| 26 Mar 2026 |
Form 4: Lo Steven, Director
Gave up 126,028 shares to cover exercise price or tax ($87.5K) |
| 26 Mar 2026 |
Form 4: Tucker Sean, SVP, Chief Scientific Officer
Gave up 36,418 shares to cover exercise price or tax ($25.3K) |
| 20 Mar 2026 |
Form 4: Berg Edward B, SVP, General Counsel
Gave up 8,072 shares to cover exercise price or tax ($5.12K) |
| 20 Mar 2026 |
Form 4: Cummings James F., Chief Medical Officer
Gave up 6,772 shares to cover exercise price or tax ($4.3K) |
| 20 Mar 2026 |
Form 4: Lo Steven, Director
Gave up 22,425 shares to cover exercise price or tax ($14.2K) |
| 20 Mar 2026 |
Form 4: Tucker Sean, SVP, Chief Scientific Officer
Gave up 8,072 shares to cover exercise price or tax ($5.12K) |
| 18 Mar 2026 |
Form 4: Lo Steven, Director
Received 846,500 shares as a grant or award · Granted 1,543,000 Stock Option (right to buy) |
Loading...